According to FutureWise analysis the market for blood screening in 2023 was US$ 2.94 billion, and is expected to reach US$ 5.6 billion by 2031 at a CAGR of 8.60%. Blood screening is a vital process in medical diagnostics and transfusion medicine that involves testing blood samples to detect infections, diseases, and various health conditions. It plays a critical role in ensuring the safety of...